• Enhancing Proteotoxic Cell Death in Prostate Cancer with Dua

  2026-05-27

  This study demonstrates that combining the cyclophilin inhibitor rencofilstat with the proteasome inhibitor ixazomib selectively increases apoptotic cell death in advanced prostate cancer cells, while sparing non-cancerous cells. These findings highlight a promising strategy for overcoming therapeutic resistance and increasing cancer cell sensitivity to proteotoxic stress.

• DiI (DiIC18(3)) Plasma Membrane Orange Fluorescent Probe Gui

  2026-05-26

  DiI (DiIC18(3)) addresses the need for robust, high-contrast plasma membrane labeling in workflows such as neuronal tracing and cell migration assays. This probe should not be used for intracellular organelle labeling or in aqueous staining protocols, as its lipophilic nature and solubility profile restrict effective use to membrane environments.

• SGI-1027 Modulates DNMT1 and RB1 to Suppress Gastric Cancer

  2026-05-26

  This study demonstrates that SGI-1027, a DNA methyltransferase inhibitor, downregulates DNMT1 and restores RB1 expression, leading to reduced proliferation and metastasis in gastric cancer models. The findings clarify the mechanistic link between epigenetic modulation and tumor suppressor gene reactivation, offering actionable insights for cancer epigenetics research.

• Anti-HMGB1 Rabbit Monoclonal Antibody: Practical Lab Guide

  2026-05-25

  The Anti-HMGB1 Rabbit Monoclonal Antibody (SKU MA3057) addresses the need for reliable, cross-species detection of HMGB1 in Western blot, immunohistochemistry, and flow cytometry workflows. This tool is not validated for diagnostic or therapeutic use and should only be employed in basic research settings.

• Crystallizing the DDX3 RNA Helicase Domain: Methodological A

  2026-05-25

  This study presents the first successful crystallization and X-ray diffraction analysis of the human DDX3 RNA helicase domain, a DEAD-box protein implicated in RNA metabolism and disease. The work distinctly demonstrates the role of spermine tetrahydrochloride as a protein crystallization additive, providing structural biologists with key parameters for reproducible results.

• SM-102 in mRNA Vaccine Delivery: Workflow, Optimization, and

  2026-05-24

  SM-102 is a high-purity synthetic lipid crucial for forming lipid nanoparticles in mRNA vaccine delivery systems, enabling efficient cellular uptake and endosomal escape. This article distills advanced workflow strategies, protocol parameters, and troubleshooting insights, drawing from recent machine learning-driven research and hands-on experimental experience, to help researchers achieve robust and reproducible results.

• Translating p53 Modulation: Strategic Use of JNJ-26854165

  2026-05-23

  This thought-leadership article examines how JNJ-26854165 (Serdemetan), a potent HDM2 ubiquitin ligase antagonist, is reshaping translational cancer research. Integrating mechanistic insights and strategic workflow guidance, it bridges in vitro rigor with clinical relevance. Researchers will discover advanced protocols, competitive context, and actionable recommendations for leveraging Serdemetan in p53 pathway modulation, anti-proliferative, apoptosis, and radiosensitization studies. The discussion synthesizes recent advances in drug response metrics and highlights how APExBIO’s offering enables reproducible, high-impact research.

• Dual-Action Inhibitors Enhance Dephosphorylation of p38α MAP

  2026-05-22

  The reference study uncovers how certain kinase inhibitors not only block p38α MAP kinase activity but also promote its dephosphorylation by stabilizing an activation loop conformation accessible to phosphatases. This dual-action mechanism offers a new strategy for improving specificity and efficacy in inflammation and vascular research.

• Deep Learning of USC Mitochondria for Non-Invasive AD Biomar

  2026-05-22

  This study introduces a deep learning framework for analyzing mitochondrial morphology in urine-derived stem cells (USCs) as a dynamic, non-invasive biomarker for Alzheimer’s disease. By leveraging advanced image segmentation and classification, the research provides a new approach to assess systemic mitochondrial dysfunction linked to cognitive impairment, with potential for early AD detection.

• Gastrin I (Human): Elevating Translational GI Pathway Resear

  2026-05-21

  This thought-leadership article examines the mechanistic underpinnings and strategic applications of Gastrin I (human) in the context of advanced in vitro models—including hiPSC-derived intestinal organoids—for gastric acid secretion pathway research. By integrating evidence from recent breakthroughs and highlighting APExBIO’s quality, it provides actionable guidance for translational investigators aiming to dissect gastrointestinal physiology and accelerate therapeutic innovation.

• Ranolazine as an Anti-Ischemic Agent: Experimental Workflows

  2026-05-21

  Ranolazine stands out as a dual-action anti-ischemic agent, enabling precise cardiac and metabolic modeling in research settings. This article delivers actionable workflows, troubleshooting strategies, and advanced applications, drawing on the latest mechanistic and protocol-focused studies.

• FOXO3-Mediated Metabolic Inhibition in Hepatocellular Carcin

  2026-05-20

  The referenced study uncovers FOXO3 as a pivotal suppressor of both glycolysis and glutaminolysis in hepatocellular carcinoma (HCC), acting via transcriptional repression of YAP. This dual metabolic targeting offers a mechanistically distinct strategy for impeding HCC growth and suggests new avenues for metabolic-based therapy.

• Mubritinib (TAK 165) as an Inhibitor of Monkeypox Virus Repl

  2026-05-20

  Chiem et al. systematically screened diverse small molecules and identified Mubritinib (TAK 165) as a potent in vitro inhibitor of monkeypox virus (MPXV) replication. Their study expands the antiviral landscape by demonstrating that mitochondrial complex I inhibition, traditionally explored in cancer research, can suppress orthopoxvirus infection, suggesting new research avenues for drug repurposing.

• AMPK Modulation Attenuates Airway Inflammation in Obesity-Re

  2026-05-19

  This study demonstrates that AMPK activation suppresses M1 macrophage polarization through the JAK2/STAT3 pathway, leading to reduced airway inflammation in obesity-related asthma. The findings highlight a mechanistic framework for targeting macrophage-mediated inflammation, suggesting new therapeutic avenues for refractory asthma subtypes.

• Sodium Orthovanadate (Na3VO4): Reliable Phosphatase Inhibiti

  2026-05-19

  This scenario-driven guide explores how Sodium Orthovanadate (SKU A8524) delivers reproducible, high-sensitivity inhibition of phosphatases for robust phosphorylation state preservation in cell assays. Integrating protocol insights and vendor comparisons, it demystifies practical workflow challenges and provides evidence-backed recommendations for biomedical researchers, lab technicians, and postgraduates.

8642 records 17/577 page Previous Next First page 上5页 1617181920 下5页 Last page